Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.70
Bid: 12.40
Ask: 13.00
Change: -0.05 (-0.39%)
Spread: 0.60 (4.839%)
Open: 13.00
High: 13.00
Low: 12.40
Prev. Close: 12.75
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: K3 Business says cash balances ahead of forecast

Wed, 20th Dec 2023 20:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Reabold Resources PLC - invests in "low-risk, near-term" oil and gas projects - Updates on LNEnergy Ltd in which company holds a 26% interest. Notes LNEnergy reports that it has filed the Environmental Impact Study for the new small-scale liquefied natural gas development plan at the Colle Santo gas field with the Ministry of Environment & Energy Security. This is a further step towards achieving the granting of a production concession at Colle Santo.

----------

Life Settlement Assets PLC - London-based closed-ended investment company which manages portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the US - Receives notification of a maturity across three policies held by the company with a face value of USD9 million. Explains the accounting for these maturities is in the process of being calculated and, if verified, would add around USD6.3 million to the company's assets equating to around 5.8% of the net asset value before costs. Will consider payment of a dividend with the proceeds.

----------

K3 Business Technology Group PLC - business-critical software solutions provider focusing on fashion and apparel brands - Updates on trading for the financial year ended November 30. Says adjusted operating profit for the year is expected to be at least in line with market expectations, and the group is expected to have closed the financial year-end with cash balances at GBP8.3 million, ahead of market expectations. These results are despite the ongoing lower demand and activity in global accounts, as previously reported.

----------

Poolbeg Pharma PLC - Clinical-stage biopharmaceutical company targeting diseases with a high unmet medical needs - Announces the positive outputs from the lab-based analysis and successful prioritisation of the respiratory syncytial virus drug targets and treatments identified as part of its artificial intelligence led programme. Actively exploring the most effective way to progress the prioritised drug candidates in order to generate value. Believes the data obtained reflects the high potential of this AI-led programme and supports its partnering efforts. Chief Executive Jeremy Skillington says: "As we engage in partnering discussions, these results position Poolbeg as a key player in the evolving landscape of AI-driven drug discovery."

----------

RA International Group PLC - specialist provider of complex and integrated remote site services - Says High Court of England and Wales makes order confirming the reduction of the share premium account by an amount of USD18.2 million. Notes the capital reduction was approved by shareholders at a General Meeting on November 22.

----------

Location Sciences Group PLC - London-based location data verification company - Expects to publish an AIM admission document in respect of the proposed acquisition of Sorted Holdings Ltd by the end of January 2024, following which will seek the restoration of trading of the company's ordinary shares on AIM. Explains that a considerable amount of work has already been carried out and the company continues to diligently progress the transaction towards completion.

----------

Adriatic Metals PLC - precious and base metals explorer and developer that owns the Vares silver project in Bosnia & Herzegovina and the Raska zinc deposit in Serbia - Reports updated ore reserve estimate for the 100%-owned Rupice silver-zinc-lead-gold deposit in Bosnia and Herzegovina has grown to: 13.8 megatonnes at 187 grammes per tonne gold, 5.2% Zinc, 3.3% lead, 1.4 grammes per tonne silver, 0.5% copper and 0.2% antimony. The significant increase in ore reserves underpins an 18-year mine life which now extends until 2041 based on nominal throughput capacity of 800,000 tonnes per annum.

----------

Belluscura PLC - London-headquartered medical device developer - Receives approval from the National Medical Products Administration to distribute the X-PLOR portable oxygen concentrator in China. With this approval secured, Belluscura has now entered into negotiations with several distributors in China. Further, says results for the financial year 2023 are marginally below management expectations at the earnings before interest, tax, depreciation and amortisation level while prospects for 2024 remain unchanged.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Jun 2024 14:52

UK shareholder meetings calendar - next 7 days

Friday 7 June 
Property Franchise Group PLCAGM
Trident Royalties PLCAGM
TruSpine Technologies PLCAGM
Monday 10 June 
Aterian PLCAGM
Griffin Mining LtdAGM
Lok'n Store Group PLCGM re takeover by Shurgard
Onward Opportunities LtdAGM
Oxford Nanopore Technologies PLCAGM
Pan African Resources PLCGM re capital reduction
Tuesday 11 June 
Ebiquity PLCAGM
Flowtech Fluidpower PLCAGM
MaxCyte IncAGM
Mobico Group PLCAGM
Newbury Racecourse PLCAGM
Nightcap PLCGM re fundraise
Phoenix Digital Assets PLCGM re up to GBP33.7 million fundraise
Tirupati Graphite PLCGM requisitioned by Walpole St Andrews Nominees
Tortilla Mexican Grill PLCAGM
Tufton Oceanic Assets LtdEGM
Wednesday 12 June 
Advanced Medical Solutions Group PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Aurora Investment Trust PLCAGM
BioPharma Credit PLCAGM
Brighton Pier Group PLCAGM
Digital 9 Infrastructure PLCAGM
EPE Special Opportunities LtdAGM
Foresight Solar Fund LtdAGM
Star Energy Group PLCAGM
Thursday 13 June 
Beacon Rise Holdings PLCAGM
Christie Group PLCAGM
Everyman Media Group PLCAGM
Hochschild Mining PLCAGM
Iofina PLCAGM
Jadestone Energy PLCAGM
Panther Metals PLCAGM
Pollen Street Group LtdAGM
Poolbeg Pharma PLCAGM
Serabi Gold PLCAGM
Smurfit Kappa Group PLCGM re WestRock deal
Sound Energy PLCAGM
Starwood European Real Estate Finance LtdAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
1 May 2024 16:39

Poolbeg Pharma celebrates full patent approval for Immunomodulator II

(Alliance News) - Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Immunomodulator II patent application.

Read more
30 Apr 2024 16:43

Poolbeg agrees 12-month option over potential Behcet's treatment

(Sharecast News) - Poolbeg Pharma announced an exclusive 12-month option agreement with Silk Road Therapeutics on Tuesday, to potentially acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX).

Read more
30 Apr 2024 16:30

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Mar 2024 11:10

Poolbeg Pharma to be granted US patent

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application.

Read more
19 Feb 2024 14:22

Director dealings: Poolbeg Pharma co-founder ups stake

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.

Read more
15 Feb 2024 16:02

TRADING UPDATES: Diversified Energy offers dividend alternative

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
12 Feb 2024 19:44

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
12 Feb 2024 14:37

Poolbeg upbeat on research into potential drug market

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced findings from independent research confirming a substantial market opportunity exceeding $10bn for its drug candidate POLB 001 on Monday, in preventing cancer immunotherapy-induced cytokine release syndrome (CRS) through oral delivery.

Read more
17 Jan 2024 13:58

Poolbeg Pharma hails POLB 001'S potential to treat CRS

(Alliance News) - Poolbeg Pharma PLC on Wednesday noted "promising" results for POLB 001's potential in treating cancer immunotherapy-induced cytokine release syndrome.

Read more
20 Dec 2023 13:54

Poolbeg makes promising progress with RSV programme

(Sharecast News) - Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.

Read more
21 Nov 2023 14:39

TRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisher

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
9 Nov 2023 16:57

IN BRIEF: Poolbeg Pharma appoints former Amryt executives to team

Poolbeg Pharma PLC - Clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Appoints a number of former executives of Amryt Pharma PLC to its leadership team. Poolbeg's Chair, Cathal Friel, co-founded both Poolbeg and Amryt Pharma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.